- Surmodics to Participate in Upcoming Investor Conferences in March and April
- Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance
- Surmodics Announces Successful Early Clinical Use of Pounce™ LP (Low Profile) Thrombectomy System, Designed to Address a Critical, Unmet Need by Facilitating Removal of Thrombi and Emboli Below the Knee
- Surmodics to Host Virtual Annual Meeting of Shareholders
- Surmodics to Report First Quarter of Fiscal 2024 Financial Results on February 1
More ▼
Key statistics
On Thursday, Surmodics Inc (SRDX:NSQ) closed at 29.34, -25.55% below its 52-week high of 39.41, set on Sep 11, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 29.22 |
---|---|
High | 29.78 |
Low | 29.18 |
Bid | 11.76 |
Offer | 36.30 |
Previous close | 28.80 |
Average volume | 43.81k |
---|---|
Shares outstanding | 14.24m |
Free float | 13.70m |
P/E (TTM) | 73.64 |
Market cap | 410.00m USD |
EPS (TTM) | 0.3911 USD |
Data delayed at least 15 minutes, as of Mar 28 2024 20:00 BST.
More ▼